Menü
sharewise zieht um Am Wochenende vom 22./23. August wird das neue sharewise die Hauptseite. Schau es dir jetzt an und sag uns, was dir fehlt. Zum neuen sharewise Was sich ändert
Dieses Wertpapier wird aktuell nicht bei uns gehandelt
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Suchergebnisse

House Of Hr Group B.v.

WKN: A3LB6J / Name: House Of Hr Group B.v. / Aktie / ? /

87,38 €
-

H&R Block Inc.

WKN: 859376 / Symbol: HRB / Name: H&R Block / Aktie / Persönl. & Haushaltsprodukte & -dienstleistungen / Mid Cap /

44,77 €
2,45 %

Haier Electronics Group Corp Ltd

WKN: A0MJ98 / Symbol: HRELF / Name: Haier Electronics / Aktie / Haushaltsgüter / Large Cap /

3,81 €
-

Heron Therapeutics Inc.

WKN: A1XB6K / Symbol: HRTX / Name: Heron Inc / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

0,27 €
6,69 %

HKR International Ltd

WKN: 877147 / Symbol: HRKIF / Name: HKR International / Aktie / Operativer Immobilienhandel / Small Cap /

0,094 €
-1,05 %

Healthcare Realty Trust

WKN: 886627 / Symbol: HR / Name: Healthcare Real / Aktie / REITs / Mid Cap /

23,40 €
-0,85 %

Hormel Foods Corp.

WKN: 850875 / Symbol: HRL / Name: Hormel Foods / Aktie / Essen & Tabak / Large Cap /

20,92 €
-0,52 %

Harrow Health Inc.

WKN: A2PBJD / Symbol: HROW / Name: Harrow Health / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

32,80 €
-1,20 %

Heritage Insurance (HRTG) Just Flashed Golden Cross Signal: Do You Buy?Photo, wide shot, wide-angle lens, soft focus,  Underwriting company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-N0Y6W7kvQQgUHnb7hSHO9TTV.png?st=2024-05-14T11%3A36%3A30Z&se=2024-05-14T13%3A36%3A30Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2024-05-13T19%3A10%3A46Z&ske=2024-05-14T19%3A10%3A46Z&sks=b&skv=2021-08-06&sig=1qvKLOloU0OWrpqzcuH7YcgBv7QI0hAOq2gAtJGiGqs%3D
Heritage Insurance (HRTG) Just Flashed Golden Cross Signal: Do You Buy?

From a technical perspective, Heritage Insurance Holdings, Inc. (HRTG) is looking like an interesting pick, as it just reached a key level of support. HRTG's 50-day simple moving average crossed

Harmony Biosciences Holdings, Inc. (HRMY) Beats Q2 Earnings and Revenue Estimates
Harmony Biosciences Holdings, Inc. (HRMY) Beats Q2 Earnings and Revenue Estimates

Harmony Biosciences Holdings, Inc. (HRMY) came out with quarterly earnings of $1.28 per share, beating the Zacks Consensus Estimate of $0.97 per share. This compares to earnings of $0.68 per share a

Horizon Technology Finance (HRZN) Lags Q2 Earnings and Revenue Estimates
Horizon Technology Finance (HRZN) Lags Q2 Earnings and Revenue Estimates

Horizon Technology Finance (HRZN) came out with quarterly earnings of $0.11 per share, missing the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.28 per share a year

HRMY Q2 Earnings Beat Estimates on Strong Wakix Sales, Stock Up
HRMY Q2 Earnings Beat Estimates on Strong Wakix Sales, Stock Up

Harmony Biosciences Holdings, Inc. HRMY reported second-quarter 2026 earnings of $1.28 per share, up from 68 cents in the year-ago quarter. The figure surpassed the Zacks Consensus Estimate of 97

Heritage Insurance (HRTG) Tops Q2 Earnings and Revenue EstimatesPhoto, wide shot, wide-angle lens,  Reinsurance company, Midday, harsh overhead sunlight, directional sunlightt, photo by Ansel Adams: https://img.midjourneyapi.xyz/temp/490045fb-8676-41a9-be7a-bcf4281c7d92.png
Heritage Insurance (HRTG) Tops Q2 Earnings and Revenue Estimates

Heritage Insurance (HRTG) came out with quarterly earnings of $2.05 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $1.55 per share a year ago. These

Curious about H&R Block (HRB) Q4 Performance? Explore Wall Street Estimates for Key Metrics
Curious about H&R Block (HRB) Q4 Performance? Explore Wall Street Estimates for Key Metrics

Wall Street analysts forecast that H&R Block (HRB) will report quarterly earnings of $2.23 per share in its upcoming release, pointing to a year-over-year decline of 1.8%. It is anticipated that

H&R Block Gears Up to Report Q4 Earnings: What's in the Cards?
H&R Block Gears Up to Report Q4 Earnings: What's in the Cards?

H&R Block, Inc. HRB is set to report its fourth-quarter fiscal 2026 results on Aug. 11, after the closing bell.

The company has an impressive earnings surprise history. HRB’s earnings surpassed the

Heron Therapeutics (HRTX) Reports Q2 Loss, Lags Revenue Estimates
Heron Therapeutics (HRTX) Reports Q2 Loss, Lags Revenue Estimates

Heron Therapeutics (HRTX) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.02 per share a year ago. These

Harrow (HROW) Reports Q2 Loss, Misses Revenue Estimates
Harrow (HROW) Reports Q2 Loss, Misses Revenue Estimates

Harrow (HROW) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.23. This compares to earnings of $0.24 per share a year ago. These figures are

H&R Block (HRB) Q4 Earnings and Revenues Surpass Estimates
H&R Block (HRB) Q4 Earnings and Revenues Surpass Estimates

H&R Block (HRB) came out with quarterly earnings of $2.38 per share, beating the Zacks Consensus Estimate of $2.23 per share. This compares to earnings of $2.27 per share a year ago. These figures

H&R Block (HRB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
H&R Block (HRB) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

H&R Block (HRB) reported $1.14 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 3.1%. EPS of $2.38 for the same period compares to $2.27 a year ago.

The

After Plunging 7.0% in 4 Weeks, Here's Why the Trend Might Reverse for Healthcare Realty Trust (HR)Photo, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
After Plunging 7.0% in 4 Weeks, Here's Why the Trend Might Reverse for Healthcare Realty Trust (HR)

A downtrend has been apparent in Healthcare Realty Trust (HR) lately with too much selling pressure. The stock has declined 7% over the past four weeks. However, given the fact that it is now in